Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?
Many nations are pursuing the rollout of SARS-CoV-2 vaccines as an exit strategy from
unprecedented COVID-19-related restrictions. However, the success of this strategy relies …
unprecedented COVID-19-related restrictions. However, the success of this strategy relies …
Learning from the past: development of safe and effective COVID-19 vaccines
The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
elicited an equally rapid response aiming to develop a COVID-19 vaccine. These efforts are …
elicited an equally rapid response aiming to develop a COVID-19 vaccine. These efforts are …
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study …
Background Increased understanding of whether individuals who have recovered from
COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We …
COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We …
Genomic evidence for reinfection with SARS-CoV-2: a case study
Background The degree of protective immunity conferred by infection with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently unknown. As such, the …
respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently unknown. As such, the …
Antibody status and incidence of SARS-CoV-2 infection in health care workers
Background The relationship between the presence of antibodies to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection …
respiratory syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection …
What reinfections mean for COVID-19
A Iwasaki - The Lancet infectious diseases, 2021 - thelancet.com
One of the key questions in predicting the course of the COVID-19 pandemic, caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is how well and how long …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is how well and how long …
[HTML][HTML] SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy
Background Reinfection with the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has been documented, raising public health concerns. SARS-CoV-2 reinfections …
CoV-2) has been documented, raising public health concerns. SARS-CoV-2 reinfections …
COVID-19 reinfections among naturally infected and vaccinated individuals
The protection against emerging SARS-CoV-2 variants by pre-existing antibodies elicited
due to the current vaccination or natural infection is a global concern. We aimed to …
due to the current vaccination or natural infection is a global concern. We aimed to …
Reinfection in patients with COVID-19: a systematic review
X Ren, J Zhou, J Guo, C Hao, M Zheng… - Global health research …, 2022 - Springer
Background With the continuation of the COVID-19 pandemic, some COVID-19 patients
have become reinfected with the virus. Viral gene sequencing has found that some of these …
have become reinfected with the virus. Viral gene sequencing has found that some of these …
Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort …
Background There is an urgent need to better understand whether individuals who have
recovered from COVID-19 are protected from future SARS-CoV-2 infection. Methods A large …
recovered from COVID-19 are protected from future SARS-CoV-2 infection. Methods A large …